Green Thumb Industries (GTII) AI Stock Analysis

• Market Cap: $2.30B
• Dividend Yield: N/A
• Average Volume (3M): 164.69K
• Price to Earnings (P/E): 58.4
• Beta (1Y): 1.19
• Revenue Growth: 7.06%
• EPS Growth: -54.16%
• Country: CA
• Employees: 4,900
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): -0.01
• Shares Outstanding: 207,177,640
• 10 Day Avg. Volume: 139,236
• 30 Day Avg. Volume: 164,689
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 0.97
• Enterprise Value/Revenue: 1.94
• Enterprise Value/Gross Profit: 3.76
• Enterprise Value/Ebitda: 6.61
• 1Y Price Target: $19.08
• Price Target Upside: 92.09% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 4

• Rating: 64 Neutral
• Price Target: C$11.50 ▲(15.81% Upside)

Green Thumb Industries' overall stock score is driven by strong financial performance and strategic growth initiatives, despite facing valuation challenges and mixed technical indicators. The cautious sentiment from the earnings call reflects ongoing industry challenges, but the company's focus on long-term growth and market expansion provides a balanced outlook.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong market demand and effective business strategies, supporting long-term expansion and stability.

Brand Performance

Strong brand performance enhances customer loyalty and market presence, contributing to sustained competitive advantage and revenue growth.

Cash Flow Management

Robust cash flow and strategic share buybacks reflect effective financial management, enhancing shareholder value and supporting future investments.

Negative Factors

Price Compression

Price compression pressures margins, potentially reducing profitability and limiting the ability to invest in growth and innovation.

Regulatory Uncertainty

Regulatory uncertainty hampers strategic planning and investment, posing risks to long-term growth and market positioning.

Increased Expenses

Rising SG&A expenses can erode profit margins, necessitating cost control measures to maintain financial health and competitive positioning.

Green Thumb Industries Business Overview & Revenue Model

Company Description

Green Thumb Industries Inc. engages in manufacture, distribution, and sale of various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, and other cannabis-related products under the Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of April 11, 2022, it owned and operated 77 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.

How the Company Makes Money

Green Thumb Industries generates revenue through several key streams, primarily from the sale of cannabis products in its retail dispensaries and through wholesale distribution to other retailers. The company's retail segment, which includes its own branded dispensaries, contributes significantly to its revenue by offering a diverse range of cannabis products, including flower, concentrates, edibles, and topicals. Additionally, GTII engages in partnerships with various brands to expand its product offerings and reach a broader audience. The company also benefits from regulatory frameworks in various states that allow for cannabis sales, contributing to its earnings growth. Their focus on innovation and product development, alongside efficient supply chain management, enhances profitability and helps to secure their position in the competitive cannabis market.

Green Thumb Industries Financial Statement Overview

Summary

Green Thumb Industries demonstrates strong revenue growth and operational efficiency, as evidenced by solid profit margins and cash flow metrics. However, the decline in net profit margin and return on equity suggests potential areas for improvement in profitability and shareholder returns. The balance sheet remains stable with manageable leverage, supporting the company's growth prospects.

Income Statement

Green Thumb Industries shows a solid revenue growth trajectory with a TTM growth rate of 14.9%, indicating strong market demand. The gross profit margin remains healthy at 52.5%, though slightly lower than previous years. Net profit margin has decreased to 4.4% TTM from 6.4% in 2024, suggesting some pressure on net earnings. EBIT and EBITDA margins are robust, reflecting efficient operational management.

Balance Sheet

The company's debt-to-equity ratio is stable at 0.29 TTM, indicating a balanced approach to leveraging. Return on equity has decreased to 1.6% TTM, which may point to challenges in generating returns on shareholder investments. The equity ratio remains strong, suggesting a solid asset base relative to liabilities.

Cash Flow

Operating cash flow is strong, with a coverage ratio close to 1, indicating good cash generation relative to net income. Free cash flow has grown significantly by 41.7% TTM, showing improved cash efficiency. The free cash flow to net income ratio is healthy, reflecting effective cash management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.15B	1.14B	1.05B	1.02B	893.56M	556.57M
Gross Profit	595.19M	601.11M	526.50M	503.96M	491.93M	304.17M
EBITDA	338.34M	392.00M	324.14M	270.28M	329.53M	200.39M
Net Income	28.96M	73.08M	36.27M	11.98M	75.44M	14.99M
Balance Sheet
Total Assets	2.55B	2.54B	2.49B	2.43B	2.39B	1.36B
Cash, Cash Equivalents and Short-Term Investments	176.92M	171.69M	161.63M	177.68M	230.42M	83.76M
Total Debt	522.74M	530.70M	570.28M	535.86M	421.69M	249.34M
Total Liabilities	748.82M	747.93M	786.80M	768.10M	766.37M	444.39M
Stockholders Equity	1.79B	1.79B	1.70B	1.67B	1.62B	910.62M
Cash Flow
Free Cash Flow	127.61M	115.00M	4.93M	-20.94M	-55.80M	36.12M
Operating Cash Flow	221.68M	195.18M	224.97M	158.56M	132.05M	95.92M
Investing Cash Flow	-153.45M	-89.54M	-227.91M	-219.95M	-280.73M	-57.27M
Financing Cash Flow	-87.44M	-95.59M	-13.11M	8.64M	295.34M	-1.55M

Green Thumb Industries Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 9.93
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GTII, the sentiment is Negative. The current price of 9.93 is below the 20-day moving average (MA) of 11.35, below the 50-day MA of 11.23, and above the 200-day MA of 9.27, indicating a neutral trend. The MACD of -0.23 indicates Positive momentum. The RSI at 40.95 is Neutral, neither overbought nor oversold. The STOCH value of 13.76 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:GTII.

Green Thumb Industries Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GTII	―	$2.30B	58.41	1.63%	―	7.06%	-54.16%
TRUL	―	C$1.89B	―	-12.60%	―	4.92%	-64.84%
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
ACB	―	C$393.48M	―	-0.70%	―	28.42%	48.33%
CURA	―	C$3.02B	―	-24.93%	―	-2.64%	1.65%
CL	―	$724.08M	―	-10.02%	―	-5.65%	73.45%
VRNO	―	$2.17B	―	-32.20%	―	-5.30%	-191.63%

Green Thumb Industries Corporate Events

Green Thumb Industries Sells Subsidiary to Agrify

On August 27, 2025, Green Thumb Industries announced the sale of its subsidiary VCP IP Holdings, LLC to Agrify Corporation for $50 million, transferring intellectual property rights of several brands. Concurrently, a license agreement was established allowing Green Thumb to continue manufacturing and distributing these brands. Additionally, Green Thumb extended a $45 million loan to Agrify, secured by a convertible note, which may be converted into Agrify common stock or pre-funded warrants, subject to certain conditions. These transactions are expected to impact Green Thumb’s operations by streamlining its brand management while maintaining a stake in Agrify, potentially influencing its market positioning and stakeholder interests.

The most recent analyst rating on (TSE:GTII) stock is a Buy with a C$11.50 price target. To see the full list of analyst forecasts on Green Thumb Industries stock, see the TSE:GTII Stock Forecast page.

Green Thumb Industries Navigates Growth and Challenges in Latest Earnings Call

Green Thumb Industries’ recent earnings call presented a balanced view of the company’s current standing, highlighting both achievements and challenges. The sentiment was mixed, with notable revenue growth and strategic investments countered by pricing pressures, a net loss, and regulatory uncertainties.

Green Thumb Industries Reports Q2 2025 Financial Results

Green Thumb Industries Inc. is a prominent national cannabis consumer packaged goods company and retailer, known for its diverse portfolio of branded cannabis products and RISE Dispensaries chain, operating across multiple U.S. markets.